Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

Journal:

Acta Biomaterialia

Published:

2025-12-19

DOI:

10.1016/j.immuni.2025.11.020

Affiliations:

27

Authors:

45

Go to article

Institutions	Authors	Share
University of Geneva (UNIGE), Switzerland	6.866667	0.15
AGORA Cancer Research Center, Switzerland	6.283333	0.14
Swiss Cancer Center Léman (SCCL), Switzerland	6.283333	0.14
Massachusetts General Hospital (MGH), United States of America (USA)	4.833333	0.11
Geneva University Hospitals (HUG), Switzerland	4.116667	0.09
Mass General Brigham, United States of America (USA)	3.333333	0.07
University of Lausanne (UNIL), Switzerland	3.000000	0.07
University Hospital of Lausanne (CHUV), UNIL, Switzerland	2.000000	0.04
TUM University Hospital Klinikum rechts der Isar (MRI), Germany	1.333333	0.03
Massachusetts Eye and Ear Infirmary (MEEI), United States of America (USA)	1.000000	0.02
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK)	1.000000	0.02
Yale University, United States of America (USA)	1.000000	0.02
Swiss Institute of Bioinformatics (SIB), Switzerland	0.750000	0.02
LICR Lausanne Branch, Switzerland	0.700000	0.02
University Hospital Zurich (UHZ), Switzerland	0.666667	0.01
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	0.500000	0.01
Kantonsspital St. Gallen, Switzerland	0.333333	0.01
University of Tübingen (Uni Tübingen), Germany	0.333333	0.01
University Hospital Tübingen (UKT), Uni Tübingen, Germany	0.333333	0.01
Harvard Medical School (HMS), United States of America (USA)	0.333333	0.01

Interested in Oncology and Carcinogenesis?